Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02359864 · ClinicalTrials.gov registry record · NA
Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease
A NA study, sponsored by Corewell Health East.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT02359864 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 2 participants.
The verdict
NCT02359864, a NA study, was terminated before completion, sponsored by Corewell Health East.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study is designed to assess the safety and toxicity/adverse events associated with the use of low dose fractionated whole brain irradiation in those patients who have been diagnosed with probable Alzheimer's disease according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria. As a secondary goal it will establish whether or not the intervention with low dose whole brain irradiation might change the recognized progression of Alzheimer's Disease. The investigators will also collect information from the florbetaben F 18 Injection (AMYVID®) positron emission tomography (PET) Scans to determine if there is any correlation between neurocognitive/quality of life scores and changes in amyloid plaque size, number and location.
Interventions
- RADIATION 5 daily fractions of 2 Gy
- RADIATION 10 daily fractions of 2 Gy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2021-02-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02359864
The ClinicalTrials.gov registry entry for NCT02359864 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 5 daily fractions of 2 Gy is the first listed.
NCT02359864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02359864 about?
NCT02359864 is a clinical study titled "Study of Low Dose Whole Brain Irradiation in the Treatment of Alzheimer's Disease". This study is designed to assess the safety and toxicity/adverse events associated with the use of low dose fractionated whole brain irradiation in those patients who have been diagnosed with probable Alzheimer's disease according to the National Institute of Neurological and Communicative Disorders...
What is the current status of trial NCT02359864?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2019-10-01. Estimated completion is 2021-02-03.
What interventions are being tested in trial NCT02359864?
The interventions under investigation include: 5 daily fractions of 2 Gy (RADIATION), 10 daily fractions of 2 Gy (RADIATION).
Who is sponsoring clinical trial NCT02359864?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.